1 views1 min read
Revive Therapeutics Announces Grant of Stock Options
TORONTO, Dec. 27, 2019 -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE:RVV), a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products, announces a grant of incentive stock options to its newly-constituted Board of Directors, totalling 4.3 million at an e... Read More...